News 2023-06-23
Porton Pharma Solutions Welcomes Dr. Wenfang Miao as CEO of Porton USA, L.L.C. and J-STAR Research, Inc., Ushering in a New Era of Pharmaceutical Innovation
Join us in welcoming Dr. Wenfang Miao (Renee) as the new CEO of Porton USA, L.L.C. and J-STAR Research, Inc., and Vice-President of Porton Pharma Solutions, LTD. Dr. Miao brings with her more than 25 years of experience in technical, operational, and strategic leadership within the pharmaceutical industry as she will navigate Porton’s overall business strategies, operations, and business development and growth in the United States. We are looking forward to Porton’s stronger foothold in pharmaceutical innovation with her leadership. We are rooting for you, Dr. Miao!
Others
More
News 2026-03-22
Porton and Jianxiang Forge Strategic Partnership to Build a New High Ground for Large-scale Peptide Drug Manufacturing
Porton and Jianxiang partner to deliver integrated peptide CDMO services from development to commercial manufacturing, offering scalable, compliant solutions for global clients.

News 2026-03-03
Porton Wins “2025 Best CRO” Award from Daewoong Pharma
Daewoong Pharma highly recognized Porton’s contributions to its drug development through active cooperation based on Porton’s excellent capabilities and expertise.